Thursday November 26 2009 | Biotechnology feed | All feeds
|
|
|
Reportlinker Adds In Vitro Diagnostics US Market ReportThursday 1st of October 2009 12:34NEW YORK, Oct. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. In Vitro Diagnostics US Market http://www.reportlinker.com/p0109780/In-Vitro-Diagnostics-US-Market.html US demand to rise 5.4% annually through 2013 The US market for in vitro diagnostic (IVD) products will increase 5.4 percent annually to $23 billion in 2013. Clinical chemistry and immunoassay methods will remain the top two IVD sciences: the former based on sales of blood glucose monitors and test strips; the latter due to the penetration of high value-added chemiluminescent products into infectious disease and drug testing markets. Nucleic acid testing products will generate the fastest demand gains among IVD products based on throughput, sensitivity, accuracy and speed advantages, especially in the detection of infectious diseases and cancer markers. Because of increasing blood glucose monitoring among diabetic patients, endocrine condition testing will remain the largest IVD application in 2013 and beyond. Evolving trends, methods to benefit most IVD products Evolving epidemiological trends and patient care approaches will impact favorably on growth opportunities for most types of IVD products. The market for clinical chemistry reagents and instruments will benefit from more diabetic patients engaging in self-blood glucose monitoring and from the expanding use of general health screening in routine patient examinations. The widening availability of chemiluminescent tests with inherent sensitivity and selectivity advantages will broaden applications for immunoassays in monitoring therapeutic drugs, detecting drugs of abuse and testing infectious diseases. Due to their ability to quantify heart attack and embolism risk prior to occurrence, hemostasis tests for D-Dimer and other cardiac parameters will provide the best growth opportunities among IVD blood testing products. Demand for nucleic acid diagnostics will expand at a strong pace as next-generation PCR (polymerase chain reaction) and microarray technologies penetrate applications involving the analysis and characterization of complex infections and tumors. DNA-based forensic, genetic and identity testing will comprise the fastest growing IVD application through 2013 as revenues from law enforcement and genetic screening markets rise. Among other IVD products, cellular analysis and anatomical pathology reagents and instruments will post the fastest gains in demand. Cellular analysis techniques will continue to dominate cervical cancer testing and penetrate additional cancer diagnostic applications. Anatomical pathology will remain the leading IVD technique for biopsy-based cancer/disease detection. Hospital labs to remain largest IVD product market Hospital laboratories will continue to comprise the largest market for IVD products because of extensive inpatient, emergency and post-surgical testing activities. The upgrading of testing services will keep independent clinical laboratories the second largest overall and fastest growing professional market served by the IVD industry. Noninstitutional point of care segments, consisting of physicians' offices and outpatient clinics, will see below average gains in IVD product demand due to the low value-added nature of tests conducted and competition from hospital and independent clinical laboratories. Home health care will comprise the fasting growing IVD market through 2013, based on the expansion of self-blood glucose monitoring by diabetic patients. However, except for diabetes testing, the home health care market will remain relatively small due to the lack of cost effective products for self-use. Study coverage This new industry study, In Vitro Diagnostics presents historical demand data (1998, 2003, 2008) plus forecasts for 2013 and 2018 by IVD product type, methodology, application and market. The study also considers key US market environment factors, evaluates market share data and profiles industry players. TABLE OF CONTENTS INTRODUCTION xiii I. EXECUTIVE SUMMARY 1 II. MARKET ENVIRONMENT 4 General 4 Macroeconomic Environment 5 Population & Demographic Trends 10 Health Care Trends 13 Acute Conditions 14 Chronic Conditions 16 Cancer & AIDS 18 Health Insurance Trends 21 National Health Expenditures 25 Medical Providers 28 Acute Care Hospitals 28 Physicians 29 Outpatient Facilities 30 Patient Activity 32 Hospital Activity 33 Surgical Procedures 33 Outpatient & Home Health Care Activity 34 IVD Product Overview 37 Regulation 37 Technology 40 Diagnostic Testing Volume 42 Clinical Laboratory Testing Services 43 Pricing Trends 45 Product Demand Patterns, 1998-2008 46 US Trade 48 International Markets 50 III. IVD PRODUCTS 54 General 54 Product Segments 56 Reagents & Consumables 59 Instruments & Systems 61 Clinical Chemistry Products 62 Professional Products 65 Reagents & Test Kits 66 Blood Glucose 67 Lipids 67 Electrolytes & Blood Gases 69 Proteins 70 Enzymes 70 Toxicology Reagents 71 Other Clinical Chemistry Reagents 71 Standards & Controls 72 Instruments & Systems 74 Applications 85 Producers 85 Self-Testing Products 86 Blood Glucose Monitoring Products 87 Test Strips & Discs 88 Monitors 90 Other Self-Testing Products 93 Immunoassay Products 94 Technology Overview 96 Competitive Immunoassays 97 Noncompetitive Immunoassays 97 Heterogeneous & Homogeneous Immunoassays 98 Labeling Techniques 98 Manual Immunoassays 100 Reagents & Test Kits 101 Enzyme Immunoassays 101 Chemiluminescent Immunoassays 102 Fluorescent Immunoassays 102 Radioimmunoassays 103 Instruments & Systems 103 Applications 104 Drug Testing 106 Therapeutic Drugs 106 Illicit Drugs 107 Infectious Disease Testing 108 Endocrine Condition Testing 108 Cancer Testing 109 Heart Disease Testing 110 Other Applications 110 Producers 111 Blood Testing Products 115 Hematology Products 116 Reagents & Consumables 117 Instruments & Systems 118 Applications 119 Producers 120 Blood Banking Products 121 Reagents & Consumables 122 Instruments & Systems 123 Applications 124 Producers 125 Hemostasis Products 127 Reagents & Consumables 128 Instruments & Systems 129 Applications 130 Producers 133 Nucleic Acid Testing Products 135 Technology Overview 137 Polymerase Chain Reaction (PCR) 138 Microarrays 139 DNA Sequencing 139 In Situ Hybridization (ISH) 140 Restriction Fragment Length Polymorphisms (RFLPs) 140 Amplified DNA Probes 140 Direct DNA Probes 143 Instruments & Systems 145 PCR Systems 145 Microarray Systems 147 Microarray Products 149 Types of Microarrays 150 IVD Applications 151 Disease Management 153 Forensic Medicine 154 Illicit Drug Testing 154 Consumables 155 Applications 157 Producers 159 Microbiology Products 159 Culture Media 160 Reagents & Consumables 161 Instruments & Systems 162 Applications 163 Producers 164 Cellular Analysis Products 165 Flow Cytometry Products 167 Reagents & Consumables 168 Instruments & Systems 168 Applications 170 Producers 170 Other Cellular Analysis Products 172 Reagents & Consumables 173 Instruments 174 Applications 176 Producers 177 Other IVD Products 177 Anatomical Pathology Products 178 Histology Products 179 Immunohistochemistry Products 181 Effusion & Visual Inspection Products 183 Visual Inspection Tests 184 Effusion Tests 185 Applications 186 Producers 187 Cytology Products 190 Reagents, Supplies & Instruments 191 Applications 193 IV. IVD APPLICATIONS 195 General 195 Endocrine Conditions 197 Diabetes Monitoring Products 199 Blood Glucose Test Strips 199 Blood Glucose Monitors 201 Other Diabetes Monitoring Products 202 Hemoglobin A1c 203 Microalbumin 204 Ketones 206 All Other Diabetes IVD Products 207 Pregnancy, Ovulation & Fertility Tests 208 Other IVD Products for Endocrine Conditions 209 Infectious Diseases 210 Sexually Transmitted Diseases 211 IVD Demand by Methodology 211 IVD Demand by Condition 212 AIDS/HIV 213 Chlamydia 216 Herpes 218 Gonorrhea 218 Other Sexually Transmitted Diseases 219 Other Infectious Diseases 220 IVD Demand by Methodology 220 IVD Demand by Condition 221 Hepatitis 222 All Other Infectious Diseases 224 Cancer 226 IVD Demand by Methodology 227 IVD Demand by Condition 228 Cervical Cancer 229 Breast Cancer 231 Prostate Cancer 233 Colorectal Cancer 234 Other Cancers 236 Drug Testing 236 Therapeutic Drug Monitoring (TDM) 238 Illicit Drug Testing 240 Heart Disease 242 Lipid Profiling 245 Cardiac Markers 246 Blood Proteins 247 Blood Grouping & Screening 248 Blood Typing & Matching 249 Blood & Bleeding Disorders 250 Forensic Medicine & Related Testing 251 Forensic Testing 252 Genetic Testing 253 Identity Testing 254 General Health Screening & Other IVD Applications 255 General Health Screening 256 Disease Detection & Other 258 V. IVD MARKETS 261 General 261 Hospitals 264 Independent Clinical Laboratories 266 Home Health Care 269 Outpatient Facilities 270 Other Markets 272 VI. INDUSTRY STRUCTURE 274 General 274 Market Share 277 Johnson & Johnson 278 Roche Holding 279 Siemens Healthcare Diagnostics 281 Abbott Laboratories 281 Beckman Coulter 282 Becton Dickinson 283 Competitive Strategies 284 Mergers & Acquisitions 285 Cooperative Agreements 290 Research & Development 294 Marketing & Distribution 296 Manufacturing 298 Company Profiles 300 454 Life Sciences, see Roche Abbott Laboratories 301 Applied Biosystems Incorporated, see Life Technologies Bayer AG 306 BD GeneOhm, see Becton Dickinson Beckman Coulter Incorporated 308 Becton, Dickinson and Company 313 Bio-Rad Laboratories Incorporated 317 bioMerieux SA 319 Biosite Incorporated, see Inverness Medical Innovations BioVeris Corporation, see Roche Celera Corporation 322 Cholestech Corporation, see Inverness Medical Innovations Cytopeia Incorporated, see Becton Dickinson Cytyc Corporation, see Hologic Dade Behring Incorporated, see Siemens Danaher Corporation 324 Digene Corporation, see QIAGEN First Check Diagnostics, see Inverness Medical Innovations Gen-Probe Incorporated 325 Hologic Incorporated 327 Inverness Medical Innovations Incorporated 329 Invitrogen Corporation, see Life Technologies Johnson & Johnson 335 Life Technologies Corporation 339 LifeScan Incorporated, see Johnson & Johnson Lumigen Incorporated, see Beckman Coulter Meridian Bioscience Incorporated 341 NimbleGen Systems Incorporated, see Roche Olympus Corporation 343 Oncogene Science Incorporated, see Siemens Ortho-Clinical Diagnostics, see Johnson & Johnson QIAGEN NV 345 Quidel Corporation 347 Redwood Toxicology Laboratory Incorporated, see Inverness Medical Innovations Roche Holding Limited 348 Siemens AG 355 Swiss Precision Diagnostics, see Inverness Medical Innovations Sysmex Corporation 360 Thermo Fisher Scientific Incorporated 363 Third Wave Technologies Incorporated, see Hologic Trinity Biotech plc 365 TriPath, see Becton Dickinson Ventana Medical Systems Incorporated, see Roche Veridex LLC, see Johnson & Johnson Other Companies Mentioned in the Study 368 LIST OF TABLES SECTION I -- EXECUTIVE SUMMARY Summary Table 3 SECTION II -- MARKET ENVIRONMENT 1 Macroeconomic Indicators 10 2 Population & Demographics 13 3 Acute Conditions by Type 16 4 Chronic Conditions by Type 18 5 Cancer & AIDS Indicators 21 6 Health Insurance Coverage of the US Population, 1998-2008 24 7 National Health Expenditures by Type & Source 27 8 Acute Care Hospitals 29 9 Physicians & Physicians' Offices 30 10 Outpatient Facilities 32 11 Hospital Activity 33 12 Surgical Procedures 34 13 Outpatient & Home Health Care Activity 36 14 Diagnostic Testing Volume 43 15 Clinical Laboratory Testing Sites & Revenues 45 16 IVD Product Demand, 1998-2008 48 17 US Trade in IVD Products 50 18 World IVD Product Demand by Region 53 SECTION III -- IVD PRODUCTS 1 IVD Demand by Product Group 56 2 IVD Product Demand by Methodology 58 3 IVD Reagent & Consumable Demand by Methodology 61 4 IVD Instrument & System Demand by Methodology 62 5 Clinical Chemistry Product Demand by Segment 65 6 Professional Clinical Chemistry Product Demand by Type 66 7 Common Clinical Chemistry Tests 76 8 Professional Clinical Chemistry Product Demand by Application 85 9 Self-Testing Clinical Chemistry Product Demand by Type 87 10 Self-Testing Clinical Chemistry Product Demand by Application 94 11 Immunoassay Product Demand by Type 96 12 Immunoassay Product Demand by Application 106 13 Blood Testing Product Demand by Methodology 116 14 Hematology Product Demand by Type 117 15 Hematology Product Demand by Application 120 16 Blood Banking Product Demand by Type 122 17 Blood Banking Product Demand by Application 125 18 Hemostasis Product Demand by Type 128 19 Hemostasis Product Demand by Application 132 20 Nucleic Acid Testing Product Demand by Type 136 21 Nucleic Acid Testing Product Demand by Application 158 22 Microbiology Product Demand by Type 160 23 Microbiology Product Demand by Application 164 24 Cellular Analysis Product Demand by Methodology 166 25 Flow Cytometry Product Demand by Type 167 26 Flow Cytometry Product Demand by Application 170 27 Other Cellular Analysis Product Demand by Type 173 28 Other Cellular Analysis Product Demand by Application 176 29 Other IVD Product Demand by Methodology 178 30 Anatomical Pathology Product Demand by Type 179 31 Anatomical Pathology Product Demand by Application 183 32 Effusion & Visual Inspection Product Demand by Type 184 33 Effusion & Visual Inspection Product Demand by Application 187 34 Cytology Product Demand by Type 190 35 Cytology Product Demand by Application 194 SECTION IV -- IVD APPLICATIONS 1 IVD Product Demand by Application 196 2 Endocrine Testing -- IVD Product Demand by Methodology & Condition 198 3 Infectious Disease Testing -- IVD Product Demand by Condition 210 4 Sexually Transmitted Disease (STD) Testing -- IVD Product Demand by Methodology 212 5 Sexually Transmitted Disease (STD) Testing -- IVD Product Demand by Condition 213 6 Other Infectious Disease Testing -- IVD Demand by Methodology 221 7 Cancer Testing -- IVD Product Demand by Methodology 228 8 Cancer Testing -- IVD Product Demand by Condition 229 9 Drug Testing -- IVD Product Demand by Methodology & Type 238 10 Heart Disease Testing -- IVD Product Demand by Methodology 245 11 Blood Grouping & Screening -- IVD Product Demand by Methodology 249 12 Forensic & Related Testing -- IVD Product Demand by Methodology 252 13 General Health Screening & Other Applications -- IVD Product Demand by Methodology & Procedure 256 SECTION V -- IVD MARKETS 1 IVD Product Demand by Market 263 2 Hospital Laboratory IVD Product Demand 266 3 Independent Clinical Laboratory IVD Product Demand 268 4 Home IVD Product Demand 270 5 Outpatient IVD Product Demand 272 6 Other Markets: IVD Product Demand 273 SECTION VI -- INDUSTRY STRUCTURE 1 US IVD Product Sales by Company, 2008 276 2 Selected Acquisitions & Divestitures 287 3 Selected Cooperative Agreements 292 LIST OF CHARTS SECTION III -- IVD PRODUCTS 1 IVD Product Demand by Methodology, 2008 58 SECTION IV -- IVD APPLICATIONS 1 IVD Product Demand by Application, 2008 197 SECTION V -- IVD MARKETS 1 IVD Product Demand by Market, 2008 263 SECTION VI -- INDUSTRY STRUCTURE 1 US IVD Product Sales, Market Share by Company, 2008 277 To order this report: In Vitro Diagnostics US Market http://www.reportlinker.com/p0109780/In-Vitro-Diagnostics-US-Market.html More market research reports here!
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker Browse other news from this organisation: Reportlinker Source PR Newswire  |
|
Nothing in this website should be used in
place of personal medical advice from your own qualified medical
practitioner. |
All rights reserved. All other trademarks recognized. |
|
